07 October 2009

Adaptimmune announces first ever clinical trial with engineered T cells designed to clear HIV infection

Researchers at Adaptimmune and the University of  Pennsylvania announce the approval of an IND and opening for enrolment of the first ever study using engineered T cells to treat HIV

« Back to News